Companies similar to SENTI BIO
Sign up to Download

31-60 of 5,816,857 results

  • cgtaresearchgroup.org
  • 1
  • 6
Our goal is to bring gene therapies for rare Central Nervous System diseases into clinical trials and use as quickly and efficiently as possible. Our first project is focused on developing a gene therapy for Huntington's disease...
Relevance: 19.72885
  • toxplusmonitoring.com
  • 1
  • 1
  • 2
Tox Plus Monitoring is a dedicated, client-focused company that caters to global nonclinical study monitoring services. We focus on pre-clinical study monitoring, toxicology, pharmacology, and gene therapy. We serve the biopharmaceutical and..
Relevance: 19.698736
  • www.scian.com
  • 1
  • 2
  • 2
SCiAN Services is a Contract Research Organization (CRO) providing integrated clinical trial services and data systems. With 30+ years of experience in IND stage clinical trials and 700 studies completed, SCiAN's therapeutic area expertise includes..
Relevance: 19.578823
  • www.mt-gene.com
  • 9
Our goal is to make the REIC gene discovered at Okayama University into practical use as a therapeutic drug for cancer. We acquired intellectual properties, have developed a formulation, have implemented preclinical trials, and are implementing..
Relevance: 19.5758
  • gene.vision
  • 1
  • 1
The gene cards aim to provide clinicians with a quick summary of each gene and the associated clinical characteristics. We are working on expanding our list of gene cards as we continue to develop the website... A resource on rare genetic eye..
Relevance: 19.554508
  • www.xylocor.com
  • 1
  • 1
  • 18
XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. In the United States, coronary artery disease is a leading cause of death and disability. Our..
Relevance: 19.424402
  • www.tissuegene.com
  • 1
  • 13
Kolon TissueGene is a Maryland-based biopharmaceutical company developing clinical-stage advanced cell therapies... At Kolon TissueGene, we are developing advanced cell therapies to target various orthopedic diseases and degenerative disorders.....
Relevance: 19.407064
  • ntrkers.org
  • 1
  • 9
The NTRKers is a global, non-profit patient group, founded by patients and loved ones living with NTRK gene fusion cancer, and supported by leading clinical experts. Changes to the NTRK gene can cause normal cells to transform into cancer cells no..
Relevance: 19.4032
  • www.copexis.com
  • 1
  • 1
Copexis offers drug development and strategic advice across and within all our areas of expertise of more than 30 years in the pharmaceutical industry and more than 40 products (proteins, peptides, small molecules, cell and gene therapy)... Our core..
Relevance: 19.342518
  • sanguinebio.com
  • 3
  • 2
  • 8
Sanguine has supported translational, clinical, and cell & gene therapy research at 35 of the top 40 global pharmaceutical and biotechnology companies, shortening timelines and validating early-stage results to increase confidence and refine..
Relevance: 19.342518
  • www.biojosciences.com
  • 2
  • 5
Biojo Sciences is a global biopharmaceutical company developing novel clinical-stage therapies that improve patient and family lives. Our approach offers an efficient development process by finding and delivering compelling clinical-stage..
Relevance: 19.333
  • www.vdb-lab.org
  • 14
  • 1
  • 8
The Grousbeck Gene Therapy Center is an academic research center devoted to the broadening of therapeutic gene transfer in modern medicine. Our focus is on internal and collaborative preclinical and clinical research studies, technology development,..
Relevance: 19.206106
  • www.n4pharma.com
  • 2
  • 2
  • 1
N4 Pharma is a pre-clinical stage specialist pharmaceutical company developing Nuvec®, a unique novel silica nanoparticle technology with patented spiky structure designed to load, protect and deliver nucleic acids (siRNA/DNA/mRNA) intracellularly..
Relevance: 19.198847
  • www.genprex.com
  • 1
  • 3
  • 33
At Genprex, we are committed to developing life-changing gene therapies for patients afflicted with cancer and diabetes. We are dedicated in our efforts to helping patients with limited or no treatment options to have access to new and advanced..
Relevance: 19.194996
  • www.sangamo.com
  • 4
  • 17
Sangamo is a genomic medicine company that seeks to help millions of people who suffer from severe diseases for which today's medicine can only offer symptom management at best. Our mission is to translate ground-breaking science into medicines that..
Relevance: 19.148195
  • www.synplogen.com
  • 1
  • 9
Synplogen Co., Ltd. is a synthetic biology startup established in February 2017, originating from Kobe University's Graduate School of Science, Technology and Innovation. Using our proprietary DNA synthesis technologies OGAB™ and Combinatorial-OGAB,..
Relevance: 18.946733
  • rithimbiologics.com
  • 1
  • 1
  • 3
Rithim Biologics is a privately held, early stage startup company developing gene therapies to treat tachycardias (fast heart rates) in humans.Utilizing gene therapies, our initial efforts are targeting atrial fibrillation (AF) and more specifically..
Relevance: 18.907974
  • www.genecure.com
  • 1
  • 1
GeneCure Biotechnologies is an emerging biotechnology company focused on developing its patented gene transfer technology into effective treatments for various genetic diseases, infectious diseases, and cancers... GeneCure's platform technology is..
Relevance: 18.893341
  • www.inspirebiotx.com
Inspire Biotherapeutics Inc. ("Inspire"), an emerging biotech company with a mission to create life-saving gene therapies for monogenic and acquired diseases of the lung, is poised to move its novel lung tropic AAV gene therapy into clinical..
Relevance: 18.812727
  • www.tesseratherapeutics.com
  • 1
  • 29
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing™, a new biotechnology designed to offer scientists and doctors the... Tessera Therapeutics is pioneering Gene Writing™-a new genome engineering technology that..
Relevance: 18.772255
  • interiusbio.com
  • 1
  • 1
  • 15
Interius BioTherapeutics is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of..
Relevance: 18.747665
  • anaxbc.com
  • 1
  • 1
With a team of industry and academic experts in Gene Editing, Epigenetics, RNA Biology, and Drug Discovery, we provide consulting services for early-stage companies, established biotech and Pharma, and financial institutions... Drug Discovery..
Relevance: 18.696457
  • www.interbiome.com
  • 1
  • 1
  • 2
Interbiome Biologics Division We manufacture investigational biologic products (including gene vectors) for use in phase 1, 2 and 3 clinical trials... We are a Contract Manufacturing Organization (CMO), helping teams prepare to take their drug..
Relevance: 18.671791
  • www.upgrade-h2020.eu
  • 5
  • 1
  • 5
UPGRADE provides a unique blend of expertise in different areas, including technology development, tissue regeneration, disease mechanisms, preclinical and clinical AMP development... UPGRADE (Unlocking Precision Gene Therapy) is a 5-year research..
Relevance: 18.65363
  • www.bionicsightllc.com
  • 1
Bionic Sight's technology focuses on restoring sight to patients with advanced stage blindness due to retinal degenerative diseases... Bionic Sight: a new treatment for advanced stage blindness combining gene therapy with a neural coding device..
Relevance: 18.588165
  • www.phormed.com
  • 1
  • 5
PhorMed, Inc., a clinical stage biopharmaceutical company founded in 2019, is developing a drug internally called RP-323 or 12-O-tetradecanoylphorbol-13-acetate (TPA) aka phorbol-12-myristate-13-acetate (PMA)... We are a biopharmaceutical company..
Relevance: 18.502806
  • www.cmttreatmentreport.com
This page tracks new and upcoming treatment options for Charcot-Marie-Tooth disease (CMT). What's in development? What's promising? What's available soon? Current topics include DTx-1252, gene therapy, PMP22 gene silencing, alpha-1 antitrypsin (AAT),..
Relevance: 18.451363
  • ct.catapult.org.uk
  • 2
  • 3
  • 3
At the Manufacturing Innovation Centre at CGT Catapult Braintree, we work in collaboration with the cell and gene therapy industry to accelerate manufacturing innovation for therapy developers, technology companies and service providers. We support..
Relevance: 18.39028
  • oncodb.org
OncoDB is an online database resource for researchers to explore abnormal patterns in gene expression as well as viral infection that are correlated to clinical features in cancer. Specifically, OncoDB integrated RNA-seq, DNA methylation, and related..
Relevance: 18.376726
  • geneverify.org
  • 9
  • 3
  • 18
Based on the published literature, about 35% of cancer patients that are normal by histology and clinical assessment have, in fact, early stage cancer based on their genetic profile. Our team of scientists at GeneVerify are developing innovative,..
Relevance: 18.347141